Search clinical trials for: vorikonazole

Total 140 results

dingshifang
Shandong Provincial Hospital; Qianfoshan Hospital; Jinan Military General Hospital and other collaborators

Unknown

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

Invasive Pulmonary Aspergillosis

China
Turku University Hospital

Completed

Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects

Healthy

Finland
Pfizer
University of Southern California

Completed

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Non-Melanoma Skin Carcinoma
Turku University Hospital

Completed

Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine (PosaBupre)

Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine

Finland
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Candidemia | Candidiasis

United States
Chong Kun Dang Pharmaceutical

Completed

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Fungal Infections | Candida Infections | Aspergillus Infections

Korea, Republic of
Sara Botros

Completed

Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Tinea Versicolor

Egypt
Seoul National University Hospital

Completed

Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM

Healthy Volunteers

Korea, Republic of
Jan-Willem C Alffenaar
UMC Utrecht; Erasmus Medical Center; Amsterdam UMC, location VUmc; Academisch Medisch... and other collaborators

Completed

Pharmacologic Optimization of Voriconazole (VORI911)

Invasive Fungal Infection | Hematological Malignancy

Netherlands
The Affiliated Hospital of Qingdao University

Completed

Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects

Healthy Adults

China
Zambon SpA

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Allergic Bronchopulmonary Aspergillosis

United Kingdom
Instituto de Investigación Hospital Universitario...

Unknown

Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy (VORIGENPHARM)

Invasive Fungal Infections

Spain
Manjunath Prakash Pai
Pfizer; TKL Research, Inc.

Completed

Pharmacokinetics of Voriconazole in Obese Subjects

Healthy

United States
Pfizer

Completed

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Scedosporium Infection
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Different Formulation of Voriconazole

Fungus Infection
Pfizer

Completed

Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Systemic Mycosis
Asan Medical Center

Terminated

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Invasive Fungal Infection

Korea, Republic of
Pfizer
Infectious Diseases Working Party (AGIHO) of the German Society of Hematology...

Completed

Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients (IDEA)

Possible Fungal Infection

Germany
Pfizer

Completed

A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections

Systemic Fungal Infections

India
Phillip Brian Smith
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease

Stem Cell Transplantation | Graft Versus Host Disease

United States
Pfizer
McLean Hospital. Belmont, MA.

Completed

To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days

Infections, Fungal

United States
Jonsson Comprehensive Cancer Center

Completed

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cancer

United States
Astellas Pharma Inc

Withdrawn

A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis

Aspergillosis/Blood | Aspergillosis/Invasive

United States
Pfizer

Completed

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection (Ve-RIFI)

Invasive Fungal Infections
Pfizer

Completed

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

Invasive Fungal Infections

China
Brynn Chappell
The Christie NHS Foundation Trust

Suspended

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy (PIVOTAL)

Aspergillosis | Immunocompromised Patient | Fusarium

United Kingdom
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Aspergillosis, Aspergilloma

Japan
Pfizer

Completed

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV

Serious Fungal Infections
Pfizer

Completed

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

Serious Fungal Infections
National Cancer Institute (NCI)

Completed

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Sarcoma | Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Neutropenia | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Pfizer
European Society for Blood and Marrow Transplantation

Completed

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI)

Prophylaxis Of Invasive Fungal Infections

Portugal, Belgium, France, Germany, Spain, United Kingdom, Switzerland, Sweden
University of Cologne

Terminated

Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

Leukemia, Myelocytic, Acute

Germany
Samyang Biopharmaceuticals Corporation

Completed

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

Systemic Mycotic Infection

Korea, Republic of
Pfizer

Completed

A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Candidemia | Aspergillosis

United States
Seoul National University Hospital

Completed

A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen

Fungal Infection

Korea, Republic of
University of Arkansas

Withdrawn

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

Aspergillosis

United States
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets

Anesthesia | Sedation

China
Pfizer

Terminated

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

Candidiasis

Hong Kong, Hungary, China, Czech Republic, Mexico, Philippines, Poland, Slovakia
Rennes University Hospital

Completed

ATCF (Azole Therapy in Cystic Fibrosis) (ATCF)

Cystic Fibrosis | Aspergillus Infections

France, United Kingdom
TFF Pharmaceuticals, Inc.

Completed

Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma

Asthma

Australia
Pfizer

Completed

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) (IMPROVIT)

Antifungal Prophylaxis of Invasive Fungal Infections

Canada, Spain, Greece, France, Portugal, United Kingdom, Czech Republic, Egypt, Jordan, Russian Federation, Switzerland, Turkey
Pfizer

Terminated

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Aspergillosis

United States
TFF Pharmaceuticals, Inc.

Available

Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Chronic Pulmonary Aspergillosis | Pulmonary Fungal Infection | Aspergillus Tracheobronchitis | Anastomotic Infection
University Medical Center Groningen

Withdrawn

Bioavailability of Voriconazole

Critically Ill | Bioavailability | Voriconazole

Netherlands
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

Unspecified Adult Solid Tumor, Protocol Specific | Infection

United States
Universidade Federal do Rio de Janeiro

Completed

Anti-mold Azole in the Prophylaxis for Invasive Fusariosis (Fusarproph)

Onychomycosis | Fusariosis

Brazil
Seoul National University Hospital

Completed

Therapeutic Drug Monitoring of Voriconazole

Mycoses

Korea, Republic of
University Health Network, Toronto

Completed

CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels

Fungal Infection | Aspergillosis Invasive

Canada
Postgraduate Institute of Medical Education and...

Active, not recruiting

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

Chronic Pulmonary Aspergillosis

India

3

Subscribe